Gaal Lubor - Insider Non-Derivative Transactions at Timber Pharmaceuticals, Inc. (TMBR) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Apr 15, 2023, Gaal Lubor's relationship to Timber Pharmaceuticals, Inc. (TMBR) is Director, and currently has 6,100 shares of Common Stock, par value $0.001 per share.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other TMBR insiders.
Data Source: SEC.
Gaal Lubor - Insider Non-Derivative Transactions at TMBR
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Apr 16, 2023 | Acquisition -- (Common Stock, par value $0.001 per share) | 4100 | 0 | 6100 |